AI BIO
Transforming Multi-Omic Data into Actionable Clinical and Industrial Intelligence
About AI BIO
AI BIO is an agile computational biology company operating at the intersection of high-performance computing, advanced AI, and translational medicine. We develop state-of-the-art predictive engines designed to transform global public health, oncology, and metabolic engineering by turning massive, multi-omic datasets into actionable clinical and industrial intelligence. Built on a culture of rapid iteration and rigorous data governance, we act as a strategic partner to medical centers, principal investigators, and enterprise healthcare networks.
Our core technical capabilities span epidemiological surveillance, oncology and clinical prediction, and AI-driven synthetic biology. We deliver custom automation that converts raw sequencing data into definitive predictive models, enabling our partners to detect emerging threats, identify early-stage oncogenic shifts, and accelerate the design of optimized biological systems for sustainable biomanufacturing.
Our Services
Epidemiological Surveillance
Automated pipelines that process real-time genomic sequences and metagenomic data to trace hospital-acquired infection vectors, detect emerging pathogenic threats, and model resistance pathways before outbreaks scale.
Oncology & Clinical Prediction
Deep learning-powered risk engines that analyze transcriptomic, genomic, and clinical variables to identify early-stage oncogenic shifts and accurately predict patient recovery trajectories and hospital length-of-stay metrics.
AI-Driven Synthetic Biology
Generative AI and graph neural network solutions that simulate complex biochemical pathways and reaction dynamics to accelerate the design of optimized bacterial hosts for biomanufacturing and sustainable biological pigments.